NCT06648083

Brief Summary

Extremely premature infants (born before 29 weeks) frequently present oral disorders. The management of these patients require assisted ventilation, enteral nutrition, and intensive daily care (procedural pain, exposure to pain, noise, and light), which can have a negative impact on their development. And more specifically on the development of oral skills. In the past decades, the standard of care has evolved and is based on less "aggressive" care and the implication of parents as caregivers. Recent data on the incidence of oral disorders in extremely premature babies are not currently available. These oral disorders have significant short-term and long-term consequences. During hospitalization, it leads to a delay in the acquisition of full oral feeding, which is defined as the absence of need for tube feeding, and is associated with prolonged hospitalization. It is also associated with a delayed development of orality, which is essential for the proper psychomotor, and cognitive development of premature infants. Strategies have been proposed to support the acquisition of oral feeding autonomy and to prevent oral feeding disorders, including tactile stimulation of orality consisting in stroking cheeks, peri-oral and intra-oral structures, but there is still no consensus on the best way to support the development of orality in this population. In this context, a tactile stimulation protocol of orality, has been implemented in the past years, in the neonatal unit of the croix-rousse hospital, based on data published in the literature. It is performed on a daily basis by nurses, and physiotherapists. In this general context marked by a less aggressive management of orality, and the implementation of an orality stimulation protocol, the main objective of ORAPREM study is to determine the corrected gestational age of oral feeding autonomy in a population of extremely premature infants born recently. Secondary objectives are 1) To analyse risk factors of delay in oral feeding autonomy, to define a subgroup of high-risk infants who could benefit from reinforced interventions to stimulate orality, and 2) To calculate the incidence of oral feeding disorders up to 24 months.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
170

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Nov 2024

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 15, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 18, 2024

Completed
14 days until next milestone

Study Start

First participant enrolled

November 1, 2024

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2025

Completed
Last Updated

October 18, 2024

Status Verified

October 1, 2024

Enrollment Period

6 months

First QC Date

October 15, 2024

Last Update Submit

October 17, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Corrected gestational age at the time of acquisition of full oral feeding

    Corrected gestational age at the time of acquisition of full oral feeding

    Up to two months

Interventions

Determine the age of acquisition of full oral feeding in extremely premature infants hospitalised in a neonatal unit where that applies a strategy of specific and individualized stimulation of orality.

Eligibility Criteria

AgeUp to 28 Weeks
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Preterm newborn born before 28 weeks and hospitalized in the neonatology service of Croix Rousse hospital

You may qualify if:

  • Infants born at a gestational age ≤ 28 weeks
  • Born between January 1, 2018 and December 31, 2021
  • Admitted in the first three days of life in the neonatology department of the Croix-Rousse hospital
  • Discharged directly to home (or to a nursery)

You may not qualify if:

  • Infants re-transferred to another department during hospitalization
  • Infants with a severe pathology requiring surgical management in the first weeks of life. Inguinal hernia repair is not concerned
  • Severe malformation
  • Refusal of the parents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Croix Rousse

Lyon, France

RECRUITING

Central Study Contacts

Pr PICAUD Jean-Charles, MD, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 15, 2024

First Posted

October 18, 2024

Study Start

November 1, 2024

Primary Completion

May 1, 2025

Study Completion

May 1, 2025

Last Updated

October 18, 2024

Record last verified: 2024-10

Locations